Position in EXEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$952,672
+$145,543 QoQ
Shares Held
22,212
+20.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss Life Asset Management Ltd holds $100,695,940 across 59 Biotechnology names. EXEL ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,574 | $36,872,593 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,525 | $23,584,835 | |
| 3 | INCY |
Incyte Corp
|
96,083 | $9,043,331 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,734 | $7,852,868 | |
| 5 | INSM |
INSMED Inc
|
18,506 | $3,026,101 | |
| 6 | MRNA |
Moderna, Inc.
|
25,661 | $1,303,578 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
12,779 | $1,242,757 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
22,212 | $952,672 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $952,672 | 22,212 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $807,129 | 18,415 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $497,004 | 12,034 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $287,445 | 6,521 | Shares | Sole | 2025-12-02 | |
| No filing history on record for this holder in this stock. | ||||||